Serum intact parathyroid hormone levels predict hospitalisation for heart failure
- T Sugimoto1,
- T Tanigawa1,
- K Onishi2,
- N Fujimoto3,
- A Matsuda1,
- S Nakamori1,
- K Matsuoka1,
- T Nakamura1,
- T Koji1,
- M Ito3
- 1 Cardiology, Matsusaka Chuo General Hospital, Matsusaka, Japan
- 2 Department of Molecular and Laboratory Medicine, Mie University Graduate School of Medicine, Tsu, Japan
- 3 Department of Cardiology, Mie University Graduate School of Medicine, Tsu, Japan
- Dr K Onishi, Department of Molecular and Laboratory Medicine, Mie University Graduate School of Medicine, 2–174 Edobashi, Tsu 514–8507, Japan; katsu{at}clin.medic.mie-u.ac.jp
- Accepted 3 September 2008
- Published Online First 10 November 2008
Abstract
Objective: To assess whether circulating levels of intact parathyroid hormone (intact PTH) in outpatients predict hospitalisation for heart failure (HF).
Methods: Eighty-eight consecutive outpatients with HF were enrolled in the study. The independent association between intact PTH and hospitalisation for HF was assessed using Cox regression analysis.
Results: Mean (SD) serum intact PTH levels significantly increased as New York Heart Association classes increased (I: 40 (21), II: 55 (24), III: 76 (46), IV: 131 (45) pg/ml). The receiver operating characteristic (ROC) curves showed intact PTH levels ≥47 pg/ml to be the optimal cut-off points for hospitalisation for HF, with sensitivity 87%, specificity 71% and area under the ROC curve 0.82 (95% CI 0.72 to 0.91). After adjustment for variables accepted to be predictors for hospitalisation due to HF (age, gender, hypertension, diabetes mellitus, atrial fibrillation, ischaemic heart disease, left ventricular ejection fraction, B-type natriuretic peptide, estimated glomerular filtration rate and cardiac drugs), intact PTH levels ≥47 pg/ml were associated with a hazard ratio of 7.13 for hospitalisation for HF (95% CI 1.79 to 28.4).
Conclusion: Serum intact PTH levels obtained in outpatients with HF were shown to be an independent predictor of hospitalisation for HF.
Footnotes
-
Competing interests: None.
-
Ethics approval: Ethics committee approval obtained.









